Gut Microbiome-targeted Therapies for Alzheimer's Disease

Overview

Journal Gut Microbes

Specialties Gastroenterology
Microbiology

Date 2023 Nov 7

PMID 37934614

Authors

Tao Zhang

Guangqi Gao

Lai-Yu Kwok

Zhihong Sun

Affiliations

Soon will be listed here.

Abstract

The advent of high-throughput 'omics' technologies has improved our knowledge of gut microbiome in human health and disease, including Alzheimer's disease (AD), a neurodegenerative disorder. Frequent bidirectional communications and mutual regulation exist between the gastrointestinal tract and the central nervous system through the gut-brain axis. A large body of research has reported a close association between the gut microbiota and AD development, and restoring a healthy gut microbiota may curb or even improve AD symptoms and progression. Thus, modulation of the gut microbiota has become a novel paradigm for clinical management of AD, and emerging effort has focused on developing potential novel strategies for preventing and/or treating the disease. In this review, we provide an overview of the connection and causal relationship between gut dysbiosis and AD, the mechanisms of gut microbiota in driving AD progression, and the successes and challenges of implementing available gut microbiome-targeted therapies (including probiotics, prebiotics, synbiotics, postbiotics, and fecal microbiota transplantation) in preventive and/or therapeutic preclinical and clinical intervention studies of AD. Finally, we discuss the future directions in this field.

Citing Articles

Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer's Disease.

Pokrzyk J, Kulczynska-Przybik A, Guzik-Makaruk E, Winkel I, Mroczko B Int J Mol Sci. 2025; 26(5).

PMID: 40076562 PMC: 11900921. DOI: 10.3390/ijms26051935.

Unveiling roles of beneficial gut bacteria and optimal diets for health.

Kumar S, Mukherjee R, Gaur P, Leal E, Lyu X, Ahmad S Front Microbiol. 2025; 16:1527755.

PMID: 40041870 PMC: 11877911. DOI: 10.3389/fmicb.2025.1527755.

Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders.

Pena-Duran E, Garcia-Galindo J, Lopez-Murillo L, Huerta-Huerta A, Balleza-Alejandri L, Beltran-Ramirez A Int J Mol Sci. 2025; 26(4).

PMID: 40004236 PMC: 11854938. DOI: 10.3390/ijms26041773.

Fecal Microbiota Transplantation Improves Cognitive Function of a Mouse Model of Alzheimer's Disease.

Jiang X, Zheng Y, Sun H, Dang Y, Yin M, Xiao M CNS Neurosci Ther. 2025; 31(2):e70259.

PMID: 39957504 PMC: 11831070. DOI: 10.1111/cns.70259.

Investigating gut alterations in Alzheimer's disease: In-depth analysis with micro- and nano-3D X-ray phase contrast tomography.

Palermo F, Marrocco N, Dacomo L, Grisafi E, Moresi V, Sanna A Sci Adv. 2025; 11(5):eadr8511.

PMID: 39889000 PMC: 11784835. DOI: 10.1126/sciadv.adr8511.

References

Teng E, Taylor K, Bilousova T, Weiland D, Pham T, Zuo X . Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization. Neurobiol Dis. 2015; 82:552-560. PMC: 4641021. DOI: 10.1016/j.nbd.2015.09.002. View

Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T . Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Res. 2019; 29(10):787-803. PMC: 6796854. DOI: 10.1038/s41422-019-0216-x. View

Park S, Lee J, Shin J, Kim J, Cha B, Lee S . Cognitive function improvement after fecal microbiota transplantation in Alzheimer's dementia patient: a case report. Curr Med Res Opin. 2021; 37(10):1739-1744. DOI: 10.1080/03007995.2021.1957807. View

Abbasi A, Rad A, Ghasempour Z, Sabahi S, Kafil H, Hasannezhad P . The biological activities of postbiotics in gastrointestinal disorders. Crit Rev Food Sci Nutr. 2021; 62(22):5983-6004. DOI: 10.1080/10408398.2021.1895061. View

Bi W, Cai S, Hang Z, Lei T, Wang D, Wang L . Transplantation of feces from mice with Alzheimer's disease promoted lung cancer growth. Biochem Biophys Res Commun. 2022; 600:67-74. DOI: 10.1016/j.bbrc.2022.01.078. View

Soriano S, Curry K, Wang Q, Chow E, Treangen T, Villapol S . Fecal Microbiota Transplantation Derived from Alzheimer's Disease Mice Worsens Brain Trauma Outcomes in Wild-Type Controls. Int J Mol Sci. 2022; 23(9). PMC: 9103830. DOI: 10.3390/ijms23094476. View

Badesso S, Cartas-Cejudo P, Espelosin M, Santamaria E, Cuadrado-Tejedor M, Garcia-Osta A . Docosahexaenoic Acid Ameliorates Contextual Fear Memory Deficits in the Tg2576 Alzheimer's Disease Mouse Model: Cellular and Molecular Correlates. Pharmaceutics. 2023; 15(1). PMC: 9866126. DOI: 10.3390/pharmaceutics15010082. View

Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E . Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature. 2023; 615(7953):668-677. PMC: 10258627. DOI: 10.1038/s41586-023-05788-0. View

Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti G . Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms. Expert Rev Neurother. 2017; 18(1):83-90. PMC: 5958896. DOI: 10.1080/14737175.2018.1400909. View

10.

Cammarota G, Ianiro G, Tilg H, Rajilic-Stojanovic M, Kump P, Satokari R . European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017; 66(4):569-580. PMC: 5529972. DOI: 10.1136/gutjnl-2016-313017. View

11.

Cryan J, ORiordan K, Sandhu K, Peterson V, Dinan T . The gut microbiome in neurological disorders. Lancet Neurol. 2019; 19(2):179-194. DOI: 10.1016/S1474-4422(19)30356-4. View

12.

Zmora N, Suez J, Elinav E . You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2018; 16(1):35-56. DOI: 10.1038/s41575-018-0061-2. View

13.

Xiao L, Feng Q, Liang S, Sonne S, Xia Z, Qiu X . A catalog of the mouse gut metagenome. Nat Biotechnol. 2015; 33(10):1103-8. DOI: 10.1038/nbt.3353. View

14.

Chandra S, Sisodia S, Vassar R . The gut microbiome in Alzheimer's disease: what we know and what remains to be explored. Mol Neurodegener. 2023; 18(1):9. PMC: 9889249. DOI: 10.1186/s13024-023-00595-7. View

15.

Arendash G, Jensen M, Salem Jr N, Hussein N, Cracchiolo J, Dickson A . A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience. 2007; 149(2):286-302. DOI: 10.1016/j.neuroscience.2007.08.018. View

16.

Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L . New mechanism of neuroinflammation in Alzheimer's disease: The activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 100:109884. DOI: 10.1016/j.pnpbp.2020.109884. View

17.

Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland T . A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017; 169(7):1276-1290.e17. DOI: 10.1016/j.cell.2017.05.018. View

18.

Mahmoudiandehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G . Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. Alzheimers Dement. 2018; 15(1):76-92. PMC: 6487485. DOI: 10.1016/j.jalz.2018.07.217. View

19.

Hoffman J, Yanckello L, Chlipala G, Hammond T, McCulloch S, Parikh I . Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model. PLoS One. 2019; 14(8):e0221828. PMC: 6713395. DOI: 10.1371/journal.pone.0221828. View

20.

Webberley T, Masetti G, Bevan R, Kerry-Smith J, Jack A, Michael D . The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer's Disease. Front Neurosci. 2022; 16:843105. PMC: 9172594. DOI: 10.3389/fnins.2022.843105. View